GREY:CNTTQ - Post by User
Post by
sobadatthison Mar 14, 2018 11:09pm
![](https://assets.stockhouse.com/kentico-cms/0342-00/images/Sprite.svg#id_Post_Views_Icon)
38 Views
Post# 27717854
People underestimate
People underestimateThe potential of the medicinal global market. The rec market is going to be great sure but just think about how big the pain and pain management market is globally and how dominated by opiates And over the counter drugs it is. Medical marijuana is in the early adoption stage and the prescriptions from doctors are only going to continue to rise as the R&D from big companies starts to get pumped into canabis. We can be certain of one thing and that pharma companies are going to want to continue making money and once medical cannabis starts to disrupt that market just watch how fast federal legalization in the states comes about so they can capitalize that lobbying money will work quickly. On top of that the amount of potential indiscovered medical benefits of cannabis is unknown.
This is I the reason I am invested in CannTrust. There Apotex partnership brings tons of value and potential to the company once a demand for cannabis based generic drugs becomes widespread. CannTrust is going to have a great place to offload all of the weed they grow. While simultaneously benefiting from the rec market.